Ledger.Open graph →

SEC Form D · Amendment · filed December 22, 2015

Gemphire Therapeutics Inc

Offering

$5.5M

Sold

$5.5M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

NORTHVILLE, MI

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (32)

David Lowenschuss · Northville, MIExec · Director Margaret Mcshane · Northville, MIExec Andy Sassine · Rancho Santa Fe, CADirector Pedro K. Lichtinger · New York, NYDirector Charles Bisgaier · Northville, MIExec · Director P. K. Hawryluk · Carmel, INDirector Mina Sooch · Northville, MIExec · Director Daniela Oniciu · Northville, MIExec Jeffrey K. Mathiesen · Northville, MIExec Kenneth Kousky · Midland, MIDirector Seth K. Reno · Northville, MIExec Deborah L. Machovec · Wahoo, NEDirector William Alaynick · San Diego, CAExec · Director Lena Soderstrom · Uppsala, V7Exec Eric O'Brien · SAN MATEO, CAExec Lawrence Chavez · Albuquerque, NMExec Vanessa Barrett · Grand Cayman, Cayman IslandsDirector Kenneth Hood · San Diego, CAExec · Director Paul Nasser · BOSTON, MADirector Amir Belson · Menlo Park, CAExec · Director Ulf Lindskog · Uppsala, V7Director Hurley Doddy · George Town, Grand Cayman, Cayman IslandsDirector Marc A. Weiser · Ann Arbor, MIExec · Director Pravin V. Gandhi · Fort Mumbai, K7Exec · Director Bala V. Deshpande · Timonium, MDExec · Director George A. Parris · Audubon, IAExec · Director Jon Cheek · SAN FRANCISCO, CAExec Jt Michelson · Albuquerque, NMExec Alan I. Bossin · Hamilton, BermudaDirector Kim H. Ng · Greenwood Village, COExec Richard F. Clement, Jr · Greenwood Village, COExec Alexander F. Bayer · GREENWOOD VILLAGE, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗